Selection and description of cancer clinical trials participants--science or happenstance?
about
Evidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groupsEvaluation of a Clinical Cancer Trial Research Training Workshop: Helping Nurses Build Capacity in Southwest Virginia.Differences in clinical trial patient attributes and outcomes according to enrollment setting.Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?Involving American Indians and medically underserved rural populations in cancer clinical trials.Can claims-based data be used to recruit black and Hispanic subjects into clinical trials?Enrollment of women and minorities in NINDS trialsRecruiting ethnically diverse general internal medicine patients for a telephone survey on physician-patient communication.Advancing the science of recruitment and retention of ethnically diverse populations.Rural-urban differences in discussions of cancer treatment clinical trials.Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.Recruiting low-income healthy women to research: an exploratory study.The Development of a Communication Tool to Facilitate the Cancer Trial Recruitment Process and Increase Research Literacy among Underrepresented Populations.Characterization of clinical study populations by race and ethnicity in biomedical literature.Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach.Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information ServiceMetrics for evaluating patient navigation during cancer diagnosis and treatment: crafting a policy-relevant research agenda for patient navigation in cancer careBarriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessmentPerceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.An institutional strategy to increase minority recruitment to therapeutic trials.African-American patients with cancer Talking About Clinical Trials (TACT) with oncologists during consultations: evaluating the efficacy of tailored health messages in a randomised controlled trial-the TACT study protocol.Inclusion and exclusion in nutrigenetics clinical research: ethical and scientific challenges.Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?Knowledge and Beliefs About Biospecimen Research Among Chinese Older Women in Chicago's Chinatown.A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.Generalizability analysis for clinical trials: a simulation study.Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.An examination of community members', researchers' and health professionals' perceptions of barriers to minority participation in medical research: an application of concept mapping.A Community-Driven Intervention for Improving Biospecimen Donation in African American Communities.
P2860
Q24682167-0281DF75-9D09-4EB3-9FCD-DB7FD89B3BFFQ30275821-0725E919-6167-466E-BAE9-7DF58064165DQ33627769-30D29E81-8971-449D-8455-5C90247F5713Q33770325-362AB369-A4CA-4096-8445-1601135F71C5Q33936007-B294295F-F6AC-472A-BA64-72E530A9714DQ34076454-234E3119-4489-4460-A787-08C46030ED05Q34555467-78C6F604-6602-4AD9-811F-D7A4DA59200DQ34723131-5F244F47-AE11-44C1-916D-0C9B7FF29BC6Q34976067-C27931FE-8AA9-4311-9935-B107B7FEFDD8Q35182004-2B5990D4-0EE0-45E4-A6B6-7559BF07035EQ35748293-2A2A8C03-3595-4DEF-B79B-37BF9E8B9844Q35788430-41B9E668-3A81-4CBA-AFF5-FCD1A03A0022Q35836190-EF2C1E55-9431-49F1-9A66-34363BDE4433Q36113147-C1423889-315F-4C02-BB26-34414793987BQ36142181-B8E7DBF7-AAA2-43F7-AB34-CEA226BA9207Q36384604-D72940DE-FE3F-4117-B089-DA318E906837Q36580597-BE4B0C02-77E8-4F32-8D77-26F13DB266E5Q36757303-6DE3B805-E899-43B5-9ED0-173B2C5F4427Q36812606-B3BBC02F-8CCA-4D17-AF3E-A8A1AAD61379Q36860832-C432AB20-9AEE-45B3-93F2-5CE350A5E821Q37097058-7AC19518-E3E1-4DFD-A149-433AC3C434E3Q37170627-08CE0457-D092-450A-8FCE-567F5FF4B1A5Q37517168-F200A007-E764-415C-B3E6-4C61D028E95BQ37981029-471C52AF-B208-47F1-BA9A-28CDED24A2E8Q38106914-562FC016-9DEA-4564-9578-208BBFFC1AE0Q38748403-F0A59953-8A84-44D3-BEF0-0E52BE8FE4F6Q39202791-B24FC338-259F-4F0E-8854-810719BD87D2Q39485105-3EC9FC2F-91EA-4C30-94E8-5AACAB9FCF01Q40363203-0F2FC749-7044-4CE2-A0A7-B9C7FAB41CE1Q47692662-FF7CDEF6-8A2E-410D-B2D6-3BB1CD39EB77Q48463432-147D427E-8691-4B55-A330-07856510E0EFQ53170875-62783541-CB28-4FEF-80D4-71CB3052D7B3Q53662245-7A97CB7B-E282-4322-8D11-C79AA0F2C6B7
P2860
Selection and description of cancer clinical trials participants--science or happenstance?
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Selection and description of c ...... ants--science or happenstance?
@ast
Selection and description of c ...... ants--science or happenstance?
@en
Selection and description of c ...... ants--science or happenstance?
@nl
type
label
Selection and description of c ...... ants--science or happenstance?
@ast
Selection and description of c ...... ants--science or happenstance?
@en
Selection and description of c ...... ants--science or happenstance?
@nl
prefLabel
Selection and description of c ...... ants--science or happenstance?
@ast
Selection and description of c ...... ants--science or happenstance?
@en
Selection and description of c ...... ants--science or happenstance?
@nl
P2860
P356
P1433
P1476
Selection and description of c ...... ants--science or happenstance?
@en
P2093
G Marie Swanson
John C Bailar
P2860
P304
P356
10.1002/CNCR.10785
P407
P577
2002-09-01T00:00:00Z